9 NZ women daily diagnosed with breast cancer; experts urge Pharmac to fast-track Keytruda funding for triple-negative breast cancer.
9 women in New Zealand are diagnosed with breast cancer daily, and experts urge Pharmac to fast-track funding for a life-saving drug, pembrolizumab (Keytruda), for the deadliest form of the disease, triple-negative breast cancer (TNBC). Between 10-15% of breast cancers are TNBC, with no funded targeted treatments in New Zealand. The drug has shown to save and extend women's lives in clinical trials.
April 02, 2024
4 Articles